Testing effectiveness (Phase 2)UnknownNCT00026429What this trial is testingDenileukin Diftitox in Treating Patients With Non-Hodgkin's LymphomaWho this might be right forLeukemiaLymphoma Pharmatech Oncology
Testing effectiveness (Phase 2)WithdrawnNCT01101412What this trial is testingAntimicrobial Solution or Saline Solution in Maintaining Catheter Patency and Preventing Catheter-Related Blood Infections in Patients With MalignanciesWho this might be right forChronic Myeloproliferative DisordersInfectionLeukemia+6 more M.D. Anderson Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00004145What this trial is testingChemotherapy Plus Biological Therapy Followed By Peripheral Stem Cell Transplantation in Treating Patients With Hematologic CancerWho this might be right forLeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+1 more University of Chicago 16
Not applicableLooking for participantsNCT05663502What this trial is testingCollecting Blood and Tissue Sample Donations for Research for HIV/AIDS-Related CancersWho this might be right forAnal CarcinomaHematopoietic and Lymphoid Cell NeoplasmHIV Infection+9 more AIDS Malignancy Consortium 200
Early research (Phase 1)Study completedNCT00107354What this trial is testingCellular Adoptive Immunotherapy in Treating Patients With Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Myelodysplastic Syndromes That Relapsed After Donor Stem Cell TransplantWho this might be right forLeukemiaMyelodysplastic Syndromes Fred Hutchinson Cancer Center
Large-scale testing (Phase 3)Study completedNCT00012051What this trial is testingChemotherapy and Peripheral Stem Cell Transplant With or Without Monoclonal Antibody Therapy in Treating Patients With Non-Hodgkin's LymphomaWho this might be right forLymphoma Commissie Voor Klinisch Toegepast Onderzoek 340
Early research (Phase 1)Looking for participantsNCT07257419What this trial is testingCD45RA-depleted CD19-CAR T Cell Consolidation After TCRαβ+/CD19 B Cell-depleted Haploidentical Hematopoietic Cell Transplantation for Relapsed/Refractory CD19+ ALL and LymphomaWho this might be right forRelapsed Pediatric ALLHematopoietic Cell TransplantationHematologic Malignancy St. Jude Children's Research Hospital 70
Testing effectiveness (Phase 2)Study completedNCT00014469What this trial is testingCombination Chemotherapy Followed by Bone Marrow Transplantation in Treating Patients With Advanced Hematologic CancerWho this might be right forGraft Versus Host DiseaseLeukemiaMyelodysplastic Syndromes+1 more Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)UnknownNCT05959694What this trial is testingA Clinical Trial on the Safety and Efficacy of TQB3909 Tablets in Patients With Recurrent or Refractory Chronic Lymphocytic Leukemia (CLL) /Small Lymphocytic Lymphoma (SLL) .Who this might be right forChronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 107
Testing effectiveness (Phase 2)Study completedNCT00027820What this trial is testingTotal-Body Irradiation and Fludarabine Phosphate Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies or Kidney CancerWho this might be right forAdult Acute Myeloid Leukemia in RemissionChildhood Acute Lymphoblastic Leukemia in RemissionChildhood Acute Myeloid Leukemia in Remission+27 more Fred Hutchinson Cancer Center 106
Testing effectiveness (Phase 2)Looking for participantsNCT07609823What this trial is testingLacutoclax (LP-108) in Patients With Relapsed/Refractory CLL/SLLWho this might be right forRelapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Guangzhou Lupeng Pharmaceutical Company LTD. 75
Testing effectiveness (Phase 2)Study completedNCT00309842What this trial is testingMyeloablative Umbilical Cord Blood Transplantation in Hematological DiseasesWho this might be right forAcute Myeloid LeukemiaAcute Lymphocytic LeukemiaChronic Myelogenous Leukemia+10 more Masonic Cancer Center, University of Minnesota 213
Early research (Phase 1)UnknownNCT00324597What this trial is testingAMG 706 and Gemcitabine in Treating Patients With Advanced Solid Tumors or LymphomaWho this might be right forLung CancerLymphomaLymphoproliferative Disorder+1 more Jonsson Comprehensive Cancer Center 18
Testing effectiveness (Phase 2)Study completedNCT00080886What this trial is testingRituximab, Carmustine; Cytarabine, Etoposide, & Melphalan; Stem Cell Transplantation for Non-Hodgkin's LymphomaWho this might be right forLymphoma University of Nebraska 68
Early research (Phase 1)Study completedNCT00569283What this trial is testingDonor Natural Killer Cell Infusion in Preventing Relapse or Graft Failure in Patients Who Have Undergone Donor Bone Marrow TransplantWho this might be right forCancer Asan Medical Center 18
Early research (Phase 1)Study completedNCT00334438What this trial is testingBortezomib, Rituximab, and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Relapsed or Refractory Low-Grade, Follicular, or Mantle Cell Non-Hodgkin's LymphomaWho this might be right forLymphoma UNC Lineberger Comprehensive Cancer Center 12
Testing effectiveness (Phase 2)Ended earlyNCT02086591What this trial is testingA Phase II Study of Doxycycline in Relapsed NHLWho this might be right forAdult Diffuse Large B-Cell LymphomaMantle Cell Lymphoma RecurrentLymphoma, Follicular+6 more University of Rochester 7
Testing effectiveness (Phase 2)WithdrawnNCT00469976What this trial is testingEnzastaurin, Carboplatin, and Gemcitabine With or Without Bevacizumab in Treating Patients With Recurrent, Stage IIIB, or Stage IV Non-Small Cell Lung CancerWho this might be right forLung Cancer Eastern Cooperative Oncology Group
Testing effectiveness (Phase 2)Study completedNCT04113226What this trial is testingAssessment of Survival and Autonomy With Rituximab Plus Chemotherapy or Rituximab Plus Lenalidomide for Elderly Patients With Relapsed Diffuse Large B-cell LymphomaWho this might be right forChemotherapyDiffuse Large B-Cell Lymphoma (DLBCL), NosElderly Centre Hospitalier Universitaire, Amiens 1
Testing effectiveness (Phase 2)Active Not RecruitingNCT01318317What this trial is testingGenetically Engineered Lymphocyte Therapy After Peripheral Blood Stem Cell Transplant in Treating Patients With High-Risk, Intermediate-Grade, B-cell Non-Hodgkin LymphomaWho this might be right forRecurrent Grade 1 Follicular LymphomaRecurrent Grade 2 Follicular LymphomaRecurrent Grade 3 Follicular Lymphoma+2 more City of Hope Medical Center 8